Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Abnormal gait, due to inflammation but not nerve injury, reflects enhanced nociception in preclinical pain models.

Piesla MJ, Leventhal L, Strassle BW, Harrison JE, Cummons TA, Lu P, Whiteside GT.

Brain Res. 2009 Oct 27;1295:89-98. doi: 10.1016/j.brainres.2009.07.091. Epub 2009 Aug 3.

PMID:
19651113
2.

Prodrugs of perzinfotel with improved oral bioavailability.

Baudy RB, Butera JA, Abou-Gharbia MA, Chen H, Harrison B, Jain U, Magolda R, Sze JY, Brandt MR, Cummons TA, Kowal D, Pangalos MN, Zupan B, Hoffmann M, May M, Mugford C, Kennedy J, Childers WE Jr.

J Med Chem. 2009 Feb 12;52(3):771-8. doi: 10.1021/jm8011799.

PMID:
19146418
3.

The persistence of a long-term negative affective state following the induction of either acute or chronic pain.

Hummel M, Lu P, Cummons TA, Whiteside GT.

Pain. 2008 Dec;140(3):436-45. doi: 10.1016/j.pain.2008.09.020. Epub 2008 Oct 21.

PMID:
18945547
4.

Pharmacological characterization of the muscarinic agonist (3R,4R)-3-(3-hexylsulfanyl-pyrazin-2-yloxy)-1-aza-bicyclo[2.2.1]heptane (WAY-132983) in in vitro and in vivo models of chronic pain.

Sullivan NR, Leventhal L, Harrison J, Smith VA, Cummons TA, Spangler TB, Sun SC, Lu P, Uveges AJ, Strassle BW, Piesla MJ, Ramdass R, Barry A, Schantz J, Adams W, Whiteside GT, Adedoyin A, Jones PG.

J Pharmacol Exp Ther. 2007 Sep;322(3):1294-304. Epub 2007 Jun 22.

PMID:
17586724
5.

Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers.

Bingham B, Jones PG, Uveges AJ, Kotnis S, Lu P, Smith VA, Sun SC, Resnick L, Chlenov M, He Y, Strassle BW, Cummons TA, Piesla MJ, Harrison JE, Whiteside GT, Kennedy JD.

Br J Pharmacol. 2007 Aug;151(7):1061-70. Epub 2007 Jun 4. Erratum in: Br J Pharmacol. 2007 Aug;151(7):1137.

6.

An estrogen receptor-beta agonist is active in models of inflammatory and chemical-induced pain.

Leventhal L, Brandt MR, Cummons TA, Piesla MJ, Rogers KE, Harris HA.

Eur J Pharmacol. 2006 Dec 28;553(1-3):146-8. Epub 2006 Sep 26.

PMID:
17056036
7.

Effects of the N-methyl-D-aspartate receptor antagonist perzinfotel [EAA-090; [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid] on chemically induced thermal hypersensitivity.

Brandt MR, Cummons TA, Potestio L, Sukoff SJ, Rosenzweig-Lipson S.

J Pharmacol Exp Ther. 2005 Jun;313(3):1379-86. Epub 2005 Mar 11.

PMID:
15764736

Supplemental Content

Loading ...
Support Center